.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BA02_Metformin.Metformin .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BA02_Metformin.Metformin| name: | Metformin |
| ATC code: | A10BA02 | route: | oral |
| n-compartments | 2 |
Metformin is an oral antihyperglycemic agent from the biguanide class, widely used for the treatment of type 2 diabetes mellitus. It is approved today and is considered the first-line pharmacological treatment for type 2 diabetes. Metformin lowers blood glucose primarily by inhibiting hepatic gluconeogenesis and improving insulin sensitivity.
Pharmacokinetic parameters based on healthy adult volunteers after a single oral dose.
Graham, GG, et al., & Williams, KM (2011). Clinical pharmacokinetics of metformin. Clinical pharmacokinetics 50(2) 81–98. DOI:10.2165/11534750-000000000-00000 PUBMED:https://pubmed.ncbi.nlm.nih.gov/21241070
Scheen, AJ (1996). Clinical pharmacokinetics of metformin. Clinical pharmacokinetics 30(5) 359–371. DOI:10.2165/00003088-199630050-00003 PUBMED:https://pubmed.ncbi.nlm.nih.gov/8743335
Dhillon, S (2019). Dapagliflozin: A Review in Type 2 Diabetes. Drugs 79(10) 1135–1146. DOI:10.1007/s40265-019-01148-3 PUBMED:https://pubmed.ncbi.nlm.nih.gov/31236801